CHO Pharma, Inc. financial statements
CHO Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | TWD 1.43M | EODHD |
| Net income | −TWD 290.01M | EODHD |
| Cash and equivalents | TWD 52.09M | EODHD |
CHO Pharma, Inc. financials on 6ix · CHO Pharma, Inc. on 6ix